Dr. Ganapathi M Bhat

Major Cancer Types Treated:

• Hematological Malignancies: Lymphoma (Hodgkin’s & Non-Hodgkin’s – NHL), Leukemia, Multiple Myeloma, Plasmacytoma, CML, Ph+ ALL etc.
• Solid Tumors: Various types including metastatic disease.
• Metastatic Carcinoma of Prostate (including hormone-resistant)
• Neuroendocrine Tumors (NET)

Sub-specialties:

• Hematopoietic Stem Cell Transplant (BMT): Autologous, Allogeneic (Matched Unrelated Donor – MUD, Haploidentical)
• Targeted Therapy
• Immunotherapy
• Cellular Therapy (including Mesenchymal Stem Cells)
• Radio-peptide Therapy (PRRT Therapy)
• Radioimmunotherapy (e.g., Zevalin for NHL)
• Regenerative Medicine Applications

Advanced Procedures Performed:

• Autologous Stem Cell Transplantation
• Allogeneic Stem Cell Transplantation (MUD & Haploidentical)
• Administration of Chemotherapy, Targeted Therapy, Immunotherapy
• Peptide Receptor Radionuclide Therapy (PRRT) for NET and Prostate Cancer
• Radioimmunotherapy (Zevalin)
• Management of Transplant-related complications (e.g., GVHD)
• Clinical application of Mesenchymal Stem Cells

Current & Past Hospital Affiliations:

• Senior Consultant, Sir H. N. Reliance Foundation Hospital, Mumbai (Current)
• Senior Consultant, Jaslok Hospital and Research Centre, Mumbai (Current)
• Consultant, HCG ICS Khubchandani Cancer Centre, Mumbai (Current)
• Medical Oncologist, Kuwait Cancer Control Centre (2002 onwards for a period)
• Consultant, Lilavati Hospital and Research Centre, Mumbai (Associated in 2002, Established Day Care Unit)

Academic & Research Roles:

• Faculty for DNB Oncology (Super-specialty) and DNB Medicine (Mumbai).
• Mentor for MSc and PhD students (Applied Biology, Mumbai University).
• Mentor for Fellowship in Medical Oncology (MUHS).
• Past Faculty at Kuwait University (MRCP-Hematology/Pathology).
• Associate Editor, Merit Research Journal of Medicine and Medical Sciences (MRJMMS).
• Reviewer for Journal of Pharmacy and Pharmacology, Science PG Publications, Sciencevier Publications.
• Editorial Member for Advances in Modern Oncology Research, International Journal of Drug Discovery.
• Academic Editor, Stem Cell International.

Key Achievements & Contributions:

• Successfully performed over 400 Hematopoietic Stem Cell Transplants.
• Performed “World’s First Case” of BMT for post-renal transplant plasmacytoma.
• Performed India’s first BMT for NHL in a seropositive patient.
• Established the first Day Care Hemato-Oncology Unit at Lilavati Hospital.
• Extensive experience with advanced therapies like PRRT and Immunotherapy.
• Significant contributions to academic teaching and research mentorship.

National & International Awards:

• Vishist Chikitsak Medal (College of Chest Physicians) – 1997
• Rajiv Gandhi Gold Medal Award (GEPRA, Bangalore) – 2012
• Mother Teresa Gold Medal Award (GEPRA, Chennai) – 2013
• Jawaharlal Nehru Gold Medal Award (GEPRA, Chennai) – 2014
• Best Medical Oncologist of India (Praxis Media, National Health Achievers Award) – 2015
• Excellent Medical Oncologist Year Award (RK Excellence National Award) – 2022

Recognitions & Honors:

• Membership in prestigious national and international oncology/hematology societies (ESMO, EHA, AACR, APBMT).
• Recognized for pioneering BMT cases.
• Held academic and leadership roles (e.g., Unit Co-Ordinator at KCCC).

Published Papers in Medical Journals:

• Coronary artery air embolism complicating a CT-guided percutaneous lung biopsy (Indian J Radiol Imaging, 2019)
• Post‑transplant Epstein–Barr Virus‑Related Lymphoproliferative Disorder (Indian J Med Paediatr Oncol, 2019)
• Loss of Human Epidermal Growth Factor Receptor 2 (HER-2) Expression after Trastuzumab Treatment… (Ann Int Med Dent Res, 2017)
• Antioxidants as precision weapons in war against cancer chemotherapyinduced toxicity… (Saudi Pharm J, 2017)
• Musculoskeletal chronic graft versus host disease – A rare complication… (South Asian J Cancer, 2017)
• Monoclonal Gammopathy in Chronic Lymphocytic Leukemia… (Indian J Med Paediatr Oncol, 2017)
• Primary Liver Sinusoidal Non-Hodgkin’s Lymphoma Presenting as Acute Liver Failure (J Clin Exp Hepatol, 2015)
• Extramedullary plasmocytoma: A rare malignancy in renal transplant recipient (Indian J Transplant, 2015)
• Malignant amelanotic melanoma – A diagnostic surprise… (J Cancer Res Ther, 2012)
• Status of stem cell therapy in type -1 diabetics (Int J Diabetes Dev Ctries, 2010)
• Combined applications of fine needle aspiration cytology and flow cytometric immunophenotyping… (CytoJournal, 2006)
• Association of congenital chromosomal syndromes and Hodgkin’s disease… (Australas J Cancer, 2006)

Books & Chapters Authored:

• Bcr-abl mutations: identification and clinical signification (Chapter 19, Hematology Today – 2009)
• Radioimmunotherapy in lymphoma (Chapter, Hematology Today – 2010)
• CNS Lymphoma- negotiating the challenges in the management (Case-based chapter, Hematology Today – 2015)
• From trial to Therapeutics: Are Mesenchymal Stem Cells Promising in cellular Therapy (Chapter 5, Frontiers in Stem Cell and Regenerative Medicine Research – 2017, Vol 4)

Contact the Cancer Rounds team to know Dr. Ganapathi Bhat consultation fee and treatment plans.The costs for treatments like Stem Cell Transplant, Immunotherapy, or PRRT Therapy can vary significantly based on the specific protocol, duration, hospital stay, supportive care needs, and donor type (for BMT).

If you are an international patient who wants to consult with Dr. Ganapathi Bhat or get treatment, can contact Cancer Rounds team for the following:

• Language Support
• Visa & Travel Assistance
• Pre-treatment Virtual Consultation

Cancer Rounds team assigns you a dedicated person to assist you with all your treatment and related procedures.

Notable Cases Handled:

• Managed numerous complex Allogeneic BMT cases, including those using MUD and Haploidentical donors.
• Successfully treated patients with refractory hematological malignancies using novel immunotherapies and targeted agents.
• Administered PRRT therapy effectively for patients with metastatic neuroendocrine tumors.
• Pioneered BMT in challenging clinical scenarios (post-renal transplant, HIV positive).

Patient Testimonials:

“We are forever grateful for Dr. Ganapathi Bhat and his team for my husband’s Bone Marrow Transplant.” – Mrs. A. Sharma“Dr. Ganapathi Bhat, the best oncologist in Mumbai. I am very thankful to him for my successful cancer treatment.” – R. Patel“Undoubtedly, Dr. Ganapathi is the best oncologist. I highly recommend him for stem cell transplant-” S. Khan

Patient-Centred Care: Dr. Bhat focuses on providing individualized care, leveraging his vast experience to tailor treatments involving chemotherapy, targeted therapy, immunotherapy, and advanced procedures like BMT and PRRT, always considering the patient’s specific condition and needs.Technology & Innovation: He is at the forefront of adopting and applying cutting-edge technologies and therapies in oncology. His expertise in Stem Cell Transplantation, PRRT, radioimmunotherapy, and cellular therapies demonstrates a commitment to offering the latest advancements. His international training ensures adherence to global best practices.